Home › Companies › CORBUS PHARMACEUTICALS HOLDINGS INC. › 2024-2025
Compiled from SEC Form N-PX filings and CORBUS PHARMACEUTICALS HOLDINGS INC.’s Form 8-K, filed 2025-05-19 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2024-2025
Explore CORBUS PHARMACEUTICALS HOLDINGS INC. in the interactive database Compare manager voting policies
These tallies are CORBUS PHARMACEUTICALS HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-19 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Yuval Cohen | 6,681,546 | -- | -- | 65,244 | 2,281,655 | Majority: yes |
| Elect Director: Alan Holmer | 6,678,977 | -- | -- | 67,813 | 2,281,655 | Majority: yes |
| Elect Director: Rachelle Jacques | 6,634,539 | -- | -- | 112,251 | 2,281,655 | Majority: yes |
| Elect Director: John Jenkins | 6,681,768 | -- | -- | 65,022 | 2,281,655 | Majority: yes |
| Elect Director: Anne Altmeyer | 6,677,977 | -- | -- | 68,813 | 2,281,655 | Majority: yes |
| Elect Director: Yong Ben | 6,667,049 | -- | -- | 79,741 | 2,281,655 | Majority: yes |
| Elect Director: Winston Kung | 6,568,610 | -- | -- | 178,180 | 2,281,655 | Majority: yes |
| Proposal 2: The proposal to ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2025, was approved based upon the following votes: | 8,841,947 | 154,305 | 32,193 | -- | -- | Majority: yes |
| Proposal 3: The votes were cast as follows with respect to the proposal to vote, on an advisory basis, on the compensation of the Company's named executive officers as described in the Company's definitive proxy statement: | 6,519,904 | 215,784 | 11,102 | -- | 2,281,655 | Majority: yes |
Source: CORBUS PHARMACEUTICALS HOLDINGS INC., Form 8-K, filed with the SEC on 2025-05-19 — read the filing on EDGAR.
Each item below shows how the 106 asset managers that disclosed a CORBUS PHARMACEUTICALS HOLDINGS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Proposal 3: The votes were cast as follows with respect to the proposal to vote, on an advisory basis, on the compensation of the Company's named executive officers as described in the Company's definitive proxy statemen”): 6,519,904 for, 215,784 against, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,236,767 outstanding shares: 53.3% for, 2% against (55% of the company cast a for/against vote).
The 105 asset managers below cast 98% of the shares they voted on this item FOR (5,786,952 for, 126,912 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 1,115,000 | 0 | 0 | 0 | For |
| Cormorant Asset Management, LP | 1,112,072 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 849,387 | 0 | 0 | 0 | For |
| Vanguard | 665,194 | 0 | 0 | 0 | For |
| BlackRock | 418,085 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 236,000 | 0 | 0 | 0 | For |
| Charles Schwab | 190,286 | 0 | 0 | 0 | For |
| Exome Asset Management LLC | 188,100 | 0 | 0 | 0 | For |
| Global X | 154,941 | 0 | 0 | 0 | For |
| Prosight Management, LP | 113,850 | 0 | 0 | 0 | For |
| State Street | 93,555 | 12 | 0 | 0 | For |
| HighVista Strategies LLC | 75,292 | 0 | 0 | 0 | For |
| Vivo Capital, LLC | 75,153 | 0 | 0 | 0 | For |
| Victory Capital | 71,646 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 53,788 | 0 | 0 | Against |
| Northern Trust | 50,412 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 50,000 | 0 | 0 | 0 | For |
| Citadel | 45,103 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 35,748 | 0 | 0 | 0 | For |
| Two Sigma | 34,559 | 0 | 0 | 0 | For |
| Fidelity | 31,003 | 0 | 0 | 0 | For |
| Stonepine Capital Management, LLC | 30,000 | 0 | 0 | 0 | For |
| AQR | 25,990 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 20,867 | 0 | 0 | Against |
| Nuveen | 17,871 | 0 | 0 | 0 | For |
Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Alan Holmer”): 6,678,977 for, 67,813 withheld, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,236,767 outstanding shares: 54.6% for, 0.6% withheld (55% of the company cast a for/withheld vote).
The 31 asset managers below cast 100% of the shares they voted on this item FOR (1,063,512 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 996 | 0 | Abstain |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Anne Altmeyer”): 6,677,977 for, 68,813 withheld, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,236,767 outstanding shares: 54.6% for, 0.6% withheld (55% of the company cast a for/withheld vote).
The 31 asset managers below cast 100% of the shares they voted on this item FOR (1,064,557 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 996 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: John Jenkins”): 6,681,768 for, 65,022 withheld, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,236,767 outstanding shares: 54.6% for, 0.6% withheld (55% of the company cast a for/withheld vote).
The 31 asset managers below cast 100% of the shares they voted on this item FOR (1,064,557 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 996 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Rachelle Jacques”): 6,634,539 for, 112,251 withheld, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,236,767 outstanding shares: 54.2% for, 1.0% withheld (55% of the company cast a for/withheld vote).
The 31 asset managers below cast 100% of the shares they voted on this item FOR (1,063,561 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 996 | 0 | Abstain |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Winston Kung”): 6,568,610 for, 178,180 withheld, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,236,767 outstanding shares: 53.7% for, 1% withheld (55% of the company cast a for/withheld vote).
The 31 asset managers below cast 100% of the shares they voted on this item FOR (961,019 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 95,142 | 0 | Abstain |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 6,696 | 0 | Abstain |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 1,700 | 0 | Abstain |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 996 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Yong Ben”): 6,667,049 for, 79,741 withheld, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,236,767 outstanding shares: 54.5% for, 0.7% withheld (55% of the company cast a for/withheld vote).
The 31 asset managers below cast 100% of the shares they voted on this item FOR (1,064,557 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 996 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Yuval Cohen”): 6,681,546 for, 65,244 withheld, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,236,767 outstanding shares: 54.6% for, 0.6% withheld (55% of the company cast a for/withheld vote).
The 31 asset managers below cast 100% of the shares they voted on this item FOR (1,064,557 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 996 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Proposal 2: The proposal to ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2025, was approved based upon the fol”): 8,841,947 for, 154,305 against, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 12,236,767 outstanding shares: 72% for, 1% against (74% of the company cast a for/against vote).
The 31 asset managers below cast 100% of the shares they voted on this item FOR (1,064,557 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 645,417 | 0 | 0 | 0 | For |
| BlackRock | 155,344 | 0 | 0 | 0 | For |
| Charles Schwab | 95,142 | 0 | 0 | 0 | For |
| Victory Capital | 33,978 | 0 | 0 | 0 | For |
| Fidelity | 27,153 | 0 | 0 | 0 | For |
| Aberdeen | 26,894 | 0 | 0 | 0 | For |
| Equitable | 16,099 | 0 | 0 | 0 | For |
| Goldman Sachs | 14,342 | 0 | 0 | 0 | For |
| Lincoln Financial | 8,100 | 0 | 0 | 0 | For |
| Northern Trust | 7,898 | 0 | 0 | 0 | For |
| Global X | 6,696 | 0 | 0 | 0 | For |
| Pacific Life | 4,740 | 0 | 0 | 0 | For |
| John Hancock | 4,203 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,404 | 0 | 0 | 0 | For |
| ProShares | 2,541 | 0 | 0 | 0 | For |
| Nationwide | 1,935 | 0 | 0 | 0 | For |
| DWS | 1,801 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| Brighthouse | 1,370 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,291 | 0 | 0 | 0 | For |
| Calvert | 996 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 926 | 0 | 0 | 0 | For |
| Voya | 844 | 0 | 0 | 0 | For |
| State Street | 492 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 400 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Ranked by the number of CORBUS PHARMACEUTICALS HOLDINGS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 12,236,767 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Octagon Capital Advisors LP | 9.11% |
| 2 | Cormorant Asset Management, LP | 9.09% |
| 3 | ORBIMED ADVISORS LLC | 6.94% |
| 4 | Vanguard | 5.44% |
| 5 | BlackRock | 3.42% |
| 6 | ARMISTICE CAPITAL, LLC | 1.93% |
| 7 | Charles Schwab | 1.56% |
| 8 | Exome Asset Management LLC | 1.54% |
| 9 | Global X | 1.27% |
| 10 | Prosight Management, LP | 0.93% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Cormorant Global Healthcare Master Fund, LP | 19.41% | DEF14A |
| Aberdeen Group plc | 10.80% | 13G |
| OrbiMed Capital LLC | 9.58% | DEF14A |
| Octagon Capital Advisors LP | 9.11% | DEF14A |
| Kenneth Griffin | 8.01% | 13G |
| BlackRock | 6.91% | 13F |
| Vanguard Group | 5.49% | 13F |
| Renaissance Technologies | 2.82% | 13F |
| Yuval Cohen | 1.91% | DEF14A |
| State Street | 1.83% | 13F |
Percentages above are of 12,236,767 shares outstanding, as reported by CORBUS PHARMACEUTICALS HOLDINGS INC. on its Form 10-Q dated 2025-05-02 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CORBUS PHARMACEUTICALS HOLDINGS INC.’s 10-Q dated 2025-05-02. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At CORBUS PHARMACEUTICALS HOLDINGS INC.'s shareholder meeting held 2025-05-15, in the 2024-2025 proxy season, 106 asset managers reported how they voted on 9 ballot items in their SEC Form N-PX filings, covering 909 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE EXECUTIVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CORBUS PHARMACEUTICALS HOLDINGS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-19.
CORBUS PHARMACEUTICALS HOLDINGS INC. proxy season coverage: 2024-2025 (this page).